68 related articles for article (PubMed ID: 3447699)
1. [Clinical experience with gallopamil in resting and exertional angina].
Scrutinio D; Lagioia R; Mangini SG; Ricci A; Mastropasqua F; Loliva F; Venezia M; Chiddo A; Rizzon P
Cardiologia; 1987 Nov; 32(11):1259-67. PubMed ID: 3447699
[No Abstract] [Full Text] [Related]
2. [Acute and long-term effects of gallopamil (D 600) in stable angina pectoris--a randomized double-blind study].
Rettig G; Sen S; Schieffer H; Bette L
Z Kardiol; 1983 Dec; 72(12):746-54. PubMed ID: 6421002
[TBL] [Abstract][Full Text] [Related]
3. [Experience with gallopamil in the treatment of exertional ischemia and in post-infarction].
Specchia G; Ferrario M; Cobelli F; Tavazzi L; de Servi S; Ghio S; Opasich C; Riccardi G
Cardiologia; 1987 Nov; 32(11):1255-7. PubMed ID: 3447698
[No Abstract] [Full Text] [Related]
4. Are all anti-anginal agents the same? Comparative evaluation of seven calcium channel blockers with placebo and propranolol in patients with chronic stable angina.
Subramanian B
Cardiologia; 1987 Nov; 32(11):1269-79. PubMed ID: 3447700
[No Abstract] [Full Text] [Related]
5. Therapeutic double blind study of Gallopamil in patients with reproducible stable angina pectoris.
Singhal SS; Bhardwaj RP; Thapar RK; Ahmad M; Bansal RK; Varma CM; Kapoor A
Indian Heart J; 1987; 39(6):7-8. PubMed ID: 3333245
[No Abstract] [Full Text] [Related]
6. Antianginal efficacy of gallopamil in comparison to nifedipine.
Rettig G; Sen S; Vogel W; Heisel A; Schieffer H; Bette L
Int J Cardiol; 1988 Jun; 19(3):315-25. PubMed ID: 3294189
[TBL] [Abstract][Full Text] [Related]
7. Randomized double-blind comparison of gallopamil and propranolol in stable angina pectoris.
Khurmi NS; O'Hara MJ; Bowles MJ; Subramanian VB; Raftery EB
Am J Cardiol; 1984 Mar; 53(6):684-8. PubMed ID: 6367415
[TBL] [Abstract][Full Text] [Related]
8. Objective evaluation of gallopamil in patients with chronic stable angina. Exercise testing, Holter monitoring, cross-sectional echocardiography and plasma levels.
Scrutinio D; Lagioia R; Mangini SG; Mastropasqua F; Ricci A; Chiddo A; Rizzon P
Eur Heart J; 1989 Feb; 10(2):168-76. PubMed ID: 2647495
[TBL] [Abstract][Full Text] [Related]
9. Gallopamil in chronic stable angina: antianginal effect and mechanism of action. A randomized, placebo-controlled, double-blind, cross-over trial.
Zanolla L; Carbonieri E; Rossi L; Marino P; Zardini P
Cardiology; 1992; 80(5-6):324-31. PubMed ID: 1451119
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of ischemic heart disease in the elderly. Comparison of diltiazem, verapamil and gallopamil].
Simonelli P; Papa A; Macciocchi B; Auriemma F; Vetrano A; Scaletta Romeo di Santillo M; Ceriello A
Minerva Cardioangiol; 1993 May; 41(5):193-204. PubMed ID: 8355859
[TBL] [Abstract][Full Text] [Related]
11. [Correlation between the clinical efficacy and pharmacokinetic profile of gallopamil].
Rengo F; Ferrari M; Ferrara N; Guerra N; Moretto R; Odierna L; Padrini R
Cardiologia; 1987 Nov; 32(11):1243-8. PubMed ID: 3447696
[No Abstract] [Full Text] [Related]
12. Comparison of acute and steady-state conditions of gallopamil therapy in stable angina pectoris.
Vilchez FG; Villarroel T; Ruano Calvo J; Vazquez de Prada JA; Martin-Duran R; San Jose JM; Pajaron A
Int J Cardiol; 1992 Oct; 37(1):91-9. PubMed ID: 1428294
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the anti-anginal activity of diltiazem during prolonged administration in subjects with exertional angina. Cross-over double-blind study in comparison with propranolol].
Novo S; Adamo L; Strano A
Cardiologia; 1985 Dec; 30(12):1153-62. PubMed ID: 3842651
[No Abstract] [Full Text] [Related]
14. [Profile of the hemodynamic effect of gallopamil at rest and during exercise by angiocardio-scintigraphic studies: preliminary data].
Tartagni F; Marchetti G; Maiello L; Dondi M; Franchi R; Magnani B
Cardiologia; 1987 Nov; 32(11):1249-53. PubMed ID: 3447697
[No Abstract] [Full Text] [Related]
15. Effects of L-carnitine on exercise tolerance in chronic stable angina: a multicenter, double-blind, randomized, placebo controlled crossover study.
Cherchi A; Lai C; Angelino F; Trucco G; Caponnetto S; Mereto PE; Rosolen G; Manzoli U; Schiavoni G; Reale A
Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):569-72. PubMed ID: 3905631
[TBL] [Abstract][Full Text] [Related]
16. A double blind cross-over comparison of bunitrolol and placebo in the treatment of angina pectoris.
Jonker JJ; de Klerk J; den Ottolander GJ
Arzneimittelforschung; 1981; 31(7):1140-2. PubMed ID: 6115654
[TBL] [Abstract][Full Text] [Related]
17. [Varying response to nifedipine during treatment of stable exertional angina pectoris: results of a double-blind, randomized, cross-over, placebo-controlled study (author's transl)].
Brügmann U; Blasini R; Goebel G; Mannes A; Dirschinger J; Rudolph W
Herz; 1982 Apr; 7(2):117-25. PubMed ID: 7044932
[No Abstract] [Full Text] [Related]
18. Double-blind crossover clinical trial of oxyfedrine and propranolol in angina pectoris.
Sagar S; Pandhi P; Anand IS; Sharma PL; Wahi PL
Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):186-9. PubMed ID: 3888857
[TBL] [Abstract][Full Text] [Related]
19. [Effects of acute administration of the levogyral beta-blocker levomoprolol on the exercise test in angina pectoris].
Lai C; Tallu B; Onnis E; Pirisi R; Cioglia G; Cherchi A
Cardiologia; 1984 Dec; 29(12):605-14. PubMed ID: 6152549
[No Abstract] [Full Text] [Related]
20. Sotalol in the treatment of angina pectoris. A double-blind cross-over study.
Kentala E; Pyörälä K; Frick MH
Ann Clin Res; 1974 Oct; 6(5):253-7. PubMed ID: 4614692
[No Abstract] [Full Text] [Related]
[Next] [New Search]
